Ketamine for Adolescent Treatment-Resistant Depression

We are seeking adolescents (age 12-18 years) with depression that has not improved with at least 2 medications to participate in a research study at the University of Minnesota.

Study activities include clinical interviews, 6 infusions of an experimental drug called Ketamine over 2 weeks, brain MRI scans and blood draws.

For more information and to find out if you or your child would qualify for our study, please call 612-626-8534.

Study team

Principal Investigator (PI):
Study Coordinator: